Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by GoodOutlook2015on Mar 02, 2018 10:31pm

149 Views

Post# 27655287

RE:RE:Extremely disappointed 😔

keepitrealhomie wrote: were you high writing this?

thinking about getting back in starting to look mighty fine.

Am I high? I don't get high but would have to to think this was a good deal. There have 15k of inventory & a 218,045,811 share Float. Yikes that is 0.0000687929 cents each share it it was 100% profit on rack pen (which its not) https://thecse.com/en/listings/life-sciences/new-age-farm-inc

Bullboard Posts

Changing Europe’s dependency on HREE from China